About: Prophylaxis and Treatment of Pregnant Women for Emerging Infections and Bioterrorism Emergencies

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prophylaxis and Treatment of Pregnant Women for Emerging Infections and Bioterrorism Emergencies Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Prophylaxis and Treatment of Pregnant Women for Emerging Infections and Bioterrorism Emergencies
Creator	Cono, Joanne Rasmussen, Sonja Cragan, Janet Jamieson, Denise
Source	Medline; PMC
abstract	Emerging infectious disease outbreaks and bioterrorism attacks warrant urgent public health and medical responses. Response plans for these events may include use of medications and vaccines for which the effects on pregnant women and fetuses are unknown. Healthcare providers must be able to discuss the benefits and risks of these interventions with their pregnant patients. Recent experiences with outbreaks of severe acute respiratory syndrome, monkeypox, and anthrax, as well as response planning for bioterrorism and pandemic influenza, illustrate the challenges of making recommendations about treatment and prophylaxis for pregnant women. Understanding the physiology of pregnancy, the factors that influence the teratogenic potential of medications and vaccines, and the infection control measures that may stop an outbreak will aid planners in making recommendations for care of pregnant women during large-scale infectious disease emergencies.
has issue date	2006-11-01(xsd:dateTime)
bibo:doi	10.3201/eid1211.060618
bibo:pmid	17283610
has license	no-cc
sha1sum (hex)	ef5660b91f755b280e59a60c59ea2eee570ee370
schema:url	https://doi.org/10.3201/eid1211.060618
resource representing a document's title	Prophylaxis and Treatment of Pregnant Women for Emerging Infections and Bioterrorism Emergencies
has PubMed Central identifier	PMC3372351
has PubMed identifier	17283610
schema:publication	Emerg Infect Dis
resource representing a document's body	covid:ef5660b91f755b280e59a60c59ea2eee570ee370#body_text
is schema:about of	named entity 'BEGINNING' named entity 'FEATURES' named entity 'CHANGES' named entity 'Prophylaxis' named entity 'pharmacokinetics' named entity 'PHYSIOLOGIC' named entity 'SPECIAL' named entity 'EMERGENCIES' named entity 'DURING PREGNANCY' named entity 'MATERNAL' named entity 'BIOTERRORISM' named entity 'PREGNANT WOMEN' named entity 'FIRST TRIMESTER' named entity 'PREGNANCY' named entity 'PROPHYLAXIS' named entity 'TREATMENT' named entity 'PEAKING' named entity 'SECOND' named entity 'PHARMACOKINETICS' named entity 'HAVE' named entity 'EFFECTS' named entity 'ORGAN SYSTEMS' named entity 'INFECTIONS' named entity 'pregnancy' named entity 'Pregnant Women' named entity 'Prophylaxis' named entity 'Physiologic' named entity 'organ systems' named entity 'pregnant woman' named entity 'Physiologic' named entity 'physiology' named entity 'amoxicillin' named entity 'fetal' named entity 'primary teeth' named entity 'absolute contraindication' named entity 'vaccine' named entity 'estrogen' named entity 'smooth muscle' named entity 'fetal' named entity 'FDA' named entity 'pregnancy' named entity 'Investigational New Drug' named entity 'vaccinia' named entity 'bioterrorism' named entity 'pregnant women' named entity 'pregnant women' named entity 'case-control studies' named entity 'enzyme' named entity 'prophylaxis' named entity 'prophylactic' named entity 'smallpox' named entity 'anthrax' named entity 'high-risk' named entity 'glomerular filtration rate' named entity 'fetal' named entity 'pregnancy' named entity 'pregnancy' named entity 'antiviral' named entity 'teratogenicity' named entity 'pregnant women' named entity 'fat-soluble' named entity 'hepatitis B' named entity 'smallpox vaccination' named entity 'safety profile' named entity 'pregnancy' named entity 'teratogenic' named entity 'organogenesis' named entity 'pregnancy' named entity 'fetus' named entity 'animal studies' named entity 'death rate' named entity 'prophylaxis' named entity 'emerging infections' named entity 'influenza vaccination' named entity 'pharmacologic agents' named entity 'serum' named entity 'CDC' named entity 'gentamicin'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software